AU2215099A - Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders - Google Patents
Methods and compositions for the diagnosis and treatment of neuropsychiatric disordersInfo
- Publication number
- AU2215099A AU2215099A AU22150/99A AU2215099A AU2215099A AU 2215099 A AU2215099 A AU 2215099A AU 22150/99 A AU22150/99 A AU 22150/99A AU 2215099 A AU2215099 A AU 2215099A AU 2215099 A AU2215099 A AU 2215099A
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- compositions
- treatment
- methods
- neuropsychiatric disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US394498A | 1998-01-08 | 1998-01-08 | |
US09003944 | 1998-01-08 | ||
PCT/US1999/000297 WO1999035290A1 (en) | 1998-01-08 | 1999-01-07 | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2215099A true AU2215099A (en) | 1999-07-26 |
Family
ID=21708343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU22150/99A Abandoned AU2215099A (en) | 1998-01-08 | 1999-01-07 | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2215099A (en) |
WO (1) | WO1999035290A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001055440A1 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
AU2001233957A1 (en) * | 2000-02-24 | 2001-09-03 | Oxford Glycosciences (Uk) Limited | Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression |
WO2004056386A2 (en) * | 2002-12-19 | 2004-07-08 | To-Bbb Holding B.V. | Nucleic acids involved in blood-brain barrier control |
-
1999
- 1999-01-07 WO PCT/US1999/000297 patent/WO1999035290A1/en active Application Filing
- 1999-01-07 AU AU22150/99A patent/AU2215099A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999035290A1 (en) | 1999-07-15 |
WO1999035290A9 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1143956A3 (en) | Compositions and methods for the treatment of anorectal disorders | |
AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
AU2124397A (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
AU698509B2 (en) | Compositions for the treatment of rheumatoid-based arthritic diseases | |
HUP9902068A3 (en) | Methods and compositions for the diagnosis and treatment of cancer | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
AU2821295A (en) | Compositions and methods for the treatment of tumors | |
AU1697197A (en) | Immunoconjugate for the treatment of aids | |
AU6786898A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
EP0981357A4 (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders | |
AU2002249983A1 (en) | Compositions and methods for diagnosis of neuropsychiatric disorders | |
CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
AU5446798A (en) | Compositions and methods for the treatment of gastrointestinal disorders | |
AU8580598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
AU6786798A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
AU2215099A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders | |
EP0979234A4 (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders | |
AU4841296A (en) | Diagnosis of and compositions and methods for the treatment of disease | |
AU8049098A (en) | Composition and methods for the treatment of inflammatory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |